Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Pediatric Multiple Sclerosis with Primary Progressive Course-Report of a Retrospective Cohort Study in Iran.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
Remission with fingolimod in a case of demyelinating polyneuropathy.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Use and medicalization of marihuana in cancer patients.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease.
Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.
MicroRNA dysregulation in multiple sclerosis.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
A salty taste to autoimmunity.

Pages